Why this study matters for choroideremia families
Choroideremia is an inherited retinal disease caused by disease-causing changes in the CHM gene. It typically leads to progressive loss of the retina, retinal pigment epithelium (RPE), and choroid—the blood-vessel layer that supports the retina. On retinal imaging, this degeneration can produce extensive areas of tissue loss and a relatively preserved central island, features that may also occur in other inherited retinal diseases.
A 2026 study in Human Genomics illustrates this important diagnostic challenge. Two affected sisters from an Algerian family had retinal findings that initially appeared “choroideremia-like.” However, comprehensive genetic testing did not identify a disease-causing variant in CHM. Instead, it revealed that both sisters had the same harmful variant in CRB1, a gene associated with autosomal recessive retinitis pigmentosa (RP).
For people and families affected by suspected choroideremia, the message is clear: retinal appearance is essential, but it may not be sufficient to determine the underlying diagnosis. Molecular genetic testing can distinguish between conditions that look similar yet arise from different genes and follow different inheritance patterns.
A choroideremia-like pattern, but a different genetic cause
The researchers evaluated the sisters using several standard ophthalmic tests. Fundus examination showed a mottled appearance and widespread RPE atrophy. Fluorescein angiography, which uses a dye to visualize retinal circulation and areas of RPE damage, showed multiple bright areas called window defects. These occur where RPE loss allows increased visibility of underlying fluorescence. Areas of more advanced chorioretinal atrophy appeared relatively darker.
Notably, imaging showed a comparatively preserved central hyperfluorescent island. Optical coherence tomography (OCT), a noninvasive scan that provides cross-sectional images of retinal layers, revealed substantial degeneration of the outer retina. The photoreceptor layer was thin, particularly toward the retinal periphery.
Together, these findings prompted consideration of a choroideremia-like phenotype. Yet the genetic result changed the interpretation. Whole-exome sequencing identified a homozygous CRB1 variant, p.Glu710Val, in both affected sisters. “Homozygous” means that each sister carried the variant in both copies of the gene. Testing of additional family members using PCR and Sanger sequencing supported autosomal recessive inheritance and segregation of the disease-associated variant within the family.
The investigators found no pathogenic variants in CHM; variants detected in that gene were classified as benign. This helped rule out molecularly confirmed choroideremia in this family.
What the CRB1 finding may do to the protein
The CRB1 gene provides instructions for the crumbs homolog 1 protein, which is important for retinal structure and function. To explore how p.Glu710Val could affect this protein, the researchers used bioinformatics and structural-modeling approaches, including PolyPhen, SWISS-MODEL, PyMOL, InterPro, and AlphaFold.
Their analysis placed amino acid 710 within a laminin G-like domain of CRB1. The altered amino acid normally participates in a stabilizing hydrogen bond with another amino acid, Gln853. Replacing glutamic acid with valine abolishes this polar interaction. According to the structural analysis, loss of this bond may destabilize the local protein structure and alter the molecular environment within this domain.
This does not simply provide a laboratory explanation for a single genetic result. It also strengthens the biological link between the CRB1 variant and the sisters’ retinal disease, connecting the DNA change to a plausible effect on protein stability.
Implications for diagnosis, care, and treatment research
This report underscores that inherited retinal degenerations can overlap substantially on clinical examination and imaging. A choroideremia-like appearance should therefore lead to careful consideration of multiple genetic causes, including genes associated with autosomal recessive RP.
The distinction matters for families. Choroideremia is linked to CHM, while the disease in this report followed an autosomal recessive pattern involving CRB1. Establishing the correct gene is central to understanding how a variant is inherited within a family and to identifying relatives who may carry a relevant variant.
It also matters for treatment development. Gene-targeted approaches are designed around a specific disease gene. A treatment strategy being studied for one genetic form of retinal degeneration cannot automatically be assumed to apply to another condition with similar retinal imaging. Precise genetic diagnosis is therefore a foundation for identifying the most relevant research opportunities and for appropriately grouping patients in future therapeutic studies.
Looking ahead
This study is described as the first ophthalmological and molecular report of autosomal recessive CRB1-related RP in Algerian patients. Its broader contribution is a reminder that inherited retinal disease diagnosis is strongest when detailed eye examinations and genetic testing are interpreted together.
As sequencing and retinal imaging become increasingly integrated, researchers will be better positioned to map the full range of CRB1-related disease, clarify why some cases resemble choroideremia, and refine gene-specific research pathways. For patients and families, this work highlights a hopeful and practical principle: a precise diagnosis begins with looking carefully at both the retina and the genes behind it.

